Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Top 20 investors in Eastern Asia that took part in the most Late funding rounds in Biotechnology industry over the recent years

Top 20 investors in Eastern Asia that took part in the most Late funding rounds in Biotechnology industry over the recent years

Intro

The top 20 investors according to the total amount of funding rounds. These are VC funds and corporate investors in Eastern Asia that have invested in Late stage over the last 3 years. They are actively investing in Biotechnology industry.
Biotechnology is the use of biology to make or develop products. It includes biopharmaceutical, genetics, and neuroscience.

Amount of Late funding rounds is 199, which is 24.3% of the total amount of rounds in the Biotechnology industry in Eastern Asia over the last 3 years.

Top 20 investors in Eastern Asia that took part in the most Late funding rounds in Biotechnology industry over the recent years
data provided by Unicorn Nest

Save this chart to use it in your presentation
Download the diagram

Key takeaways

  • Funds Geography – The majority of VCs are located in China while others are in South Korea. There is an equal amount of VCs in Shanghai and Hong Kong Island which host 7 funds each. There are also funds from Beijing and Yeoksamdong. There are 2 countries that funds tend to invest in: China and The United States with the majority investing in China. For the majority of the funds, the country of the funds’ establishment and the country of their most frequent investments coincide.
  • Industry Focus – The funds’ most common field for investments is Finance. They also invest in Medical Service, Bio & Nano Technology and Business Development.
  • Important Years – The oldest fund in the sample was founded in 1974 and the newest one in 2018. In 2017 the most amount of funds were founded. VCs in the sample made the most deals in the period from 2016 to 2021. For some funds, 2018 was the year with the most amount of deals. The biggest amount of successful exits happened between 2014 and 2020 years. For some funds, 2020 became the year with the most successful exits.
  • Investments – Usually VCs take part in 2 funding rounds per year, sometimes in 13 – 24. The minimum number of funding rounds for VCs in the sample is 10, the maximum is 620. Average number of funding rounds is 115.0 while median is 37.5. Minimum amount of lead investments for funds is 1 and maximum is 204. Average amount of lead investments is 31.8 while median is 10.0. The most common amount of lead investments is 4. Index of difference in percentage points of lead investments from the average is between -42.43 and 22.1 for funds in the sample. The average value for this difference is -0.52 and the median is 3.53. It means that these funds act as lead investors more often than other funds. The most common value is 9.0.
  • Typical Rounds – Funding rounds with these VCs have 5 – 6 or 4 – 5 investors. VCs in the sample have an average round size of 100-500 million and 50 – 100 million. A Funds’ average multiplicator for portfolio companies at the last known valuation is close to zero at minimum and 6.77 at maximum. Average value for this multiplicator is 2.18 and median is 0.96. The most common multiplicator value is close to zero.
Biotechnology Eastern Asia Late Stage Venture
Looking for investments?
We help you to get a list of investors based on your personal choice
Crunchbase icon

Content report

The following text will be sent to our editors: